Follow-up Study on Chronic Myeloid Leukemia Patients Achieving Treatment-free Remission

NCT05439889•National Taiwan University Hospital

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Chronic Myeloid Leukemia, BCR/ABL-Positive

Locations

Taiwan

Locations (1)

National Taiwan University Hospital

Taipei, Taiwan

Key Dates

Start Date

August 11, 2022

Primary Completion Date

August 11, 2028

Completion Date

August 11, 2032

Last Updated

May 17, 2024

Contacts

Wen-Chien Chou, MD. PhD.

CONTACT

+886-2312-3456 wchou@ntu.edu.tw

Sponsors

Lead Sponsor

National Taiwan University Hospital

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 17, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions